LONG-TERM METERED-DOSE INHALER ADHERENCE IN A CLINICAL-TRIAL

被引:138
|
作者
RAND, CS
NIDES, M
COWLES, MK
WISE, RA
CONNETT, J
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DIV PULM & CRIT CARE MED, BALTIMORE, MD 21218 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90024 USA
[3] UNIV MINNESOTA, DIV BIOSTAT, MINNEAPOLIS, MN 55455 USA
[4] CASE WESTERN RESERVE UNIV, CLEVELAND, OH 44106 USA
[5] HENRY FORD HOSP, DETROIT, MI 48202 USA
[6] MAYO CLIN, ROCHESTER, MN USA
[7] OREGON HLTH SCI UNIV, PORTLAND, OR 97201 USA
[8] UNIV ALABAMA, BIRMINGHAM, AL USA
[9] UNIV MANITOBA, WINNIPEG, MB R3T 2N2, CANADA
[10] UNIV MINNESOTA, CTR COORDINATING, MINNEAPOLIS, MN 55455 USA
[11] UNIV MIAMI, CORAL GABLES, FL 33124 USA
[12] UNIV PITTSBURGH, PITTSBURGH, PA 15260 USA
[13] UNIV UTAH, SALT LAKE CITY, UT 84112 USA
[14] NHLBI, DIV LUNG DIS, BETHESDA, MD USA
关键词
D O I
10.1164/ajrccm.152.2.7633711
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Poor adherence to medication regimens is a well-documented phenomenon in clinical practice and an ever-present concern in clinical trials. Little is known about adherence to inhaled medication regimens over extended periods. The present paper describes the 2-yr results of the Lung Health Study (LHS) program, which was developed to maintain long-term adherence to an inhaled medication regimen in 3,923 special intervention participants (as measured by self-report and medication canister weight). The LHS is a double-blind, multicenter, randomized controlled clinical trial of smoking intervention and bronchodilator therapy (ipratropium bromide or placebo) for early intervention in chronic obstructive pulmonary disease (COPD). At the first 4-mo follow-up visit, nearly 70% of participants reported satisfactory or better adherence. Over the next 18 mo, self-reported satisfactory or better adherence declined to about 60%. Canister weight classified adherence as satisfactory or better in 72% of participants returning all canisters at 1 yr, and in 70% of the participants returning all canisters at the 2-yr follow-up. Self-reporting confirmed by canister weight classified 48% of participants at 1 yr as showing satisfactory or better adherence. Overusers were 50% more likely than others to misrepresent their true smoking status, suggesting that canister weights indicating overuse may be deceptive. Results of multiple logistic regression analysis indicate that the best compliance was found in participants who were married, older, white, had more severe airways obstruction, less shortness of breath, and fewer hospitalizations, and who had not been confined to bed for respiratory illnesses. In summary, a structured program for promoting adherence to an inhaled medication regimen was successful in achieving initial satisfactory adherence in the majority of participants; however, adherence declined notably from the conclusion of this program to the first-year follow-up, and more gradually over the second year.
引用
收藏
页码:580 / 588
页数:9
相关论文
共 50 条
  • [1] METERED-DOSE INHALER ADHERENCE IN A CLINICAL-TRIAL
    RAND, CS
    WISE, RA
    NIDES, M
    SIMMONS, MS
    BLEECKER, ER
    KUSEK, JW
    LI, VC
    TASHKIN, DP
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (06): : 1559 - 1564
  • [2] Long-term safety of levalbuterol administered via metered-dose inhaler in patients with asthma
    Parsey, M. V.
    D'Urzo, A. D.
    Marcus, M. G.
    Tripp, K.
    McVicar, W. K.
    Baumgartner, R. A.
    CHEST, 2006, 130 (04) : 164S - 164S
  • [3] Long-term safety of flunisolide hydrofluoroalkane metered-dose inhaler in adults and adolescents with asthma
    Casale, TB
    Nelson, HS
    Corren, J
    Newman, K
    CLINICAL DRUG INVESTIGATION, 2001, 21 (11) : 755 - 764
  • [4] Long-Term Safety of Flunisolide Hydrofluoroalkane Metered-Dose Inhaler in Adults and Adolescents with Asthma
    Thomas B. Casale
    Harold S. Nelson
    Jonathan Corren
    Kenneth Newman
    Clinical Drug Investigation, 2001, 21 : 755 - 764
  • [5] Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma
    Hamilos, Daniel L.
    D'Urzo, Anthony
    Levy, Robin J.
    Marcus, Michael
    Tripp, Kenneth
    Parsey, Merdad
    Baumgartner, Rudolf A.
    McVicar, William K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 99 (06) : 540 - 548
  • [6] Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler
    Aviram, Joshua
    Atzmony, Daniella
    Eisenberg, Elon
    PAIN REPORTS, 2022, 7 (03) : E1011
  • [7] Nonprescription Epinephrine Metered-Dose Inhaler: To Be or Not To Be
    Blake, Kathryn
    Raissy, Hengameh
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2014, 27 (03) : 143 - 146
  • [8] Recommendation for modified metered-dose inhaler
    Ahmed, S
    Gunaratnam, NT
    Patton, WF
    AMERICAN FAMILY PHYSICIAN, 2002, 66 (08) : 1401 - 1401
  • [9] INHALATION OF THE CAP OF A METERED-DOSE INHALER
    LI, JTC
    GUNDERSON, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06): : 431 - 431
  • [10] PENTAMIDINE PROPHYLAXIS WITH A METERED-DOSE INHALER
    MILLER, RF
    BUCKLAND, JA
    PANG, M
    QIU, J
    TAYLOR, KMG
    LANCET, 1991, 337 (8755): : 1489 - 1489